InvestorsHub Logo
Followers 66
Posts 1221
Boards Moderated 0
Alias Born 04/02/2020

Re: tonysd57 post# 93292

Sunday, 07/12/2020 3:09:46 PM

Sunday, July 12, 2020 3:09:46 PM

Post# of 232297
Forgive my ignorance of the process but, I was hoping to hear from someone with a scientific background and/or who intimately knows the FDA review process on this question.

Leronlimab has been thoroughly tested for HIV with no serious adverse side effects... so, the FDA has significant data to support Leronlimab as a safe drug to administer to a broad range of people.

Phase 2 mild to moderate is a double blind placebo trial...

What would be the purpose/logic of a follow-on mild to moderate Phase 3 trial if the Phase 2 results are strong and confirm CytoDyn’s efficacy?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News